Taiwan FDA registration b94d54dcf59c327032eda564cbfa09fe
Bajie III Glucose Tube Solution (Unsterilized)
TW: 百捷 III 葡萄糖品管液 (未滅菌)
Taiwan·Risk Class 1·Qinli Biotechnology Co., Ltd. new tree factory·Registered Feb 25, 2016 – Feb 25, 2026ExpiredRegistration details
- Analysis ID
- b94d54dcf59c327032eda564cbfa09fe
Company information
- Manufacturer
- Qinli Biotechnology Co., Ltd. new tree factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- GENERAL LIFE BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- Limited to the classification and grading management of medical equipment, quality control materials (analytical and non-analytical) (A.1660) the first level identification range.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- Domestic
Dates and status
- Registration Date
- Feb 25, 2016
- Expiry Date
- Feb 25, 2026
About this record
Access comprehensive regulatory information for Bajie III Glucose Tube Solution (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number b94d54dcf59c327032eda564cbfa09fe and manufactured by Qinli Biotechnology Co., Ltd. new tree factory. The authorized representative in Taiwan is GENERAL LIFE BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices